Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRVS Corvus Pharmaceuticals, Inc.

盘前交易 12-16 05:50:14 EST

8.39

+0.02

+0.24%

最高8.56	最低8.20	成交量142.07万
今开8.43	昨收8.37	日振幅4.24%
总市值6.27亿	流通市值4.81亿	总股本7,468万
成交额1,191万	换手率2.48%	流通股本5,736万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRVS","market":"US","secType":"STK","nameCN":"Corvus Pharmaceuticals, Inc.","latestPrice":8.39,"timestamp":1765832400000,"preClose":8.37,"halted":0,"volume":1420726,"delay":0,"floatShares":57356272,"shares":74681872,"eps":-0.558655,"marketStatus":"盘前交易","change":0.02,"latestTime":"12-16 05:50:14 EST","open":8.43,"high":8.555,"low":8.2,"amount":11910897.94442,"amplitude":0.042413,"askPrice":9.67,"askSize":100,"bidPrice":7.55,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.558655,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765895400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1458705600000,"exchange":"NASDAQ","adjPreClose":8.39,"postHourTrading":{"tag":"盘后","latestPrice":8.26,"preClose":8.39,"latestTime":"19:24 EST","volume":8794,"amount":73644.095,"timestamp":1765844698889},"volumeRatio":0.848456711385282,"impliedVol":1.4542,"impliedVolPercentile":0.7871},"requestUrl":"/m/hq/s/CRVS/tweets","defaultTab":"tweets","newsList":[{"id":"2582826302","title":"Corvus Pharmaceuticals, Inc.2025财年第三财季实现净利润-10.16百万美元，同比增加74.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582826302","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582826302?lang=zh_cn&edition=full","pubTime":"2025-11-10 00:01","pubTimestamp":1762704096,"startTime":"0","endTime":"0","summary":"11月10日，Corvus Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第三财季净利润为-10.16百万美元，同比增加74.74%；其中营业收入为0.00美元，每股基本收益为-0.12美元。从资产负债表来看，Corvus Pharmaceuticals, Inc.总负债8.71百万美元，其中短期债务379000.00美元，资产负债比为9.24，流动比率为8.30。机构评级：截至2025年11月10日，当前有6家机构对Corvus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为15.33美元，其中最低目标价为11.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110000223a4950663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110000223a4950663&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS"],"gpt_icon":0},{"id":"2580278511","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅下挫5.10%报7.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580278511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580278511?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:32","pubTimestamp":1762180323,"startTime":"0","endTime":"0","summary":"北京时间2025年11月03日22时32分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.10%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Tharimmune, Inc.、Phio Pharmaceuticals Corp.、Terns Pharmaceuticals, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Biodexa Pharmaceuticals Plc、Tharimmune, Inc.较为活跃，换手率分别为1435.29%、335.96%、305.44%，振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Tharimmune, Inc.、Terns Pharmaceuticals, Inc.，振幅分别为62.77%、46.78%、21.79%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110322320497512f32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110322320497512f32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"1123437692","title":"Corvus Pharmaceuticals宣布在2025年欧洲医学肿瘤学会年会上展示Ciforadenant针对转移性肾细胞癌患者的1B/2期临床试验中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1123437692","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123437692?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:01","pubTimestamp":1760709671,"startTime":"0","endTime":"0","summary":"Corvus Pharmaceuticals宣布在2025年欧洲医学肿瘤学会年会上展示Ciforadenant针对转移性肾细胞癌患者的1B/2期临床试验中期数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2565519597","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅上涨5.06%报6.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565519597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565519597?lang=zh_cn&edition=full","pubTime":"2025-09-06 00:22","pubTimestamp":1757089351,"startTime":"0","endTime":"0","summary":"北京时间2025年09月06日00时22分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.06%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250906002231a7124520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250906002231a7124520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4085","VS","BK4568"],"gpt_icon":0},{"id":"2557578314","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578314?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:44","pubTimestamp":1754660660,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时44分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.93%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808214420a47d6052&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808214420a47d6052&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2556638701","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556638701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556638701?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:16","pubTimestamp":1754317019,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时16分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.00%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804221700973306f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804221700973306f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2556900853","title":"Corvus Pharmaceuticals, Inc.盘中异动 快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556900853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556900853?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:59","pubTimestamp":1753991979,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时59分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.02%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801035940972af822&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801035940972af822&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2551135927","title":"Corvus Pharmaceuticals, Inc.盘中异动 临近收盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551135927?lang=zh_cn&edition=full","pubTime":"2025-07-15 03:57","pubTimestamp":1752523036,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日03时57分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715035717a44a8edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715035717a44a8edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2550657446","title":"Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.05%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550657446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550657446?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:52","pubTimestamp":1752083540,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日01时52分，Corvus Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.05%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710015221953c6a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710015221953c6a89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2548819244","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548819244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548819244?lang=zh_cn&edition=full","pubTime":"2025-07-03 00:22","pubTimestamp":1751473337,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日00时22分，Corvus Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.05%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507030022179534231a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507030022179534231a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2548600058","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548600058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548600058?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:28","pubTimestamp":1751380119,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日22时28分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.00%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012228399796034a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012228399796034a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2546744461","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546744461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546744461?lang=zh_cn&edition=full","pubTime":"2025-06-27 22:18","pubTimestamp":1751033882,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时18分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.23%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722180297917d64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722180297917d64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2545239866","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545239866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545239866?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:36","pubTimestamp":1750775796,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日22时36分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.09%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624223637a4bbad2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624223637a4bbad2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2545448376","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545448376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545448376?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:27","pubTimestamp":1750688845,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时27分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.05%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623222725a7190d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623222725a7190d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2543544778","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543544778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543544778?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:36","pubTimestamp":1749756993,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时36分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.00%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Klotho Neurosciences, Inc.较为活跃，换手率分别为3818.50%、925.68%、386.68%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.，振幅分别为256.24%、171.50%、102.43%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033633a705e5d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033633a705e5d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2518272633","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518272633?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:03","pubTimestamp":1741615414,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时03分，Corvus Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.19%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为672.40%、342.08%、93.86%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Pmgc Holdings Inc.，振幅分别为41.36%、40.24%、32.14%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220335a26a3104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220335a26a3104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2517164364","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517164364?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:40","pubTimestamp":1741275643,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时40分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.33%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Plus Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为2212.44%、1590.75%、85.87%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为68.33%、67.37%、49.27%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306234043963c5ac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306234043963c5ac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2514433086","title":"Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514433086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514433086?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:57","pubTimestamp":1740689829,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时57分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.06%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1955.27%、424.52%、198.31%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045710a256d079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045710a256d079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2514862265","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.52%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862265?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:28","pubTimestamp":1740601714,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时28分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.52%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6844.95%、332.32%、265.02%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270428359893eace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270428359893eace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2514013012","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013012?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:18","pubTimestamp":1740496685,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时18分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.13%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Lava Therapeutics N.V.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1050.65%、845.70%、586.00%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、63.66%、61.16%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231805abdc89ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231805abdc89ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corvusbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0433},{"period":"3month","weight":0.4617},{"period":"6month","weight":1.1349},{"period":"1year","weight":0.1369},{"period":"ytd","weight":0.5682}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corvus Pharmaceuticals, Inc.于2014年1月27日在特拉华州注册成立,并于2014年11月开始运作。该公司是一家临床阶段的生物制药公司，专注于发展和商业化那些旨在利用免疫系统攻击癌细胞的新免疫治疗肿瘤方案。自从2014年11月开始运营起，已建成四个免疫肿瘤的方案，其中三个重点腺苷癌症轴调节免疫反应的管道。该公司的主导候选产品，CPI-444，A2A受体腺苷，免疫检查点的口服小分子拮抗剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.022575},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.054432},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.007101},{"month":4,"riseRate":0.4,"avgChangeRate":-0.074037},{"month":5,"riseRate":0.7,"avgChangeRate":0.293143},{"month":6,"riseRate":0.3,"avgChangeRate":-0.062415},{"month":7,"riseRate":0.5,"avgChangeRate":0.054478},{"month":8,"riseRate":0.7,"avgChangeRate":0.146907},{"month":9,"riseRate":0.5,"avgChangeRate":0.106125},{"month":10,"riseRate":0.4,"avgChangeRate":0.017628},{"month":11,"riseRate":0.6,"avgChangeRate":0.004343},{"month":12,"riseRate":0.2,"avgChangeRate":-0.058712}],"exchange":"NASDAQ","name":"Corvus Pharmaceuticals, Inc.","nameEN":"Corvus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corvus Pharmaceuticals, Inc.,CRVS,Corvus Pharmaceuticals, Inc.股票,Corvus Pharmaceuticals, Inc.股票老虎,Corvus Pharmaceuticals, Inc.股票老虎国际,Corvus Pharmaceuticals, Inc.行情,Corvus Pharmaceuticals, Inc.股票行情,Corvus Pharmaceuticals, Inc.股价,Corvus Pharmaceuticals, Inc.股市,Corvus Pharmaceuticals, Inc.股票价格,Corvus Pharmaceuticals, Inc.股票交易,Corvus Pharmaceuticals, Inc.股票购买,Corvus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}